I am a driven and enthusiastic Nano-biomedical scientist with over 9 years of experience specializing in biomaterials, regenerative medicine, and drug delivery systems. My research focuses on developing, validating, and integrating advanced experimental and computational models, including in-vitro and in-silico platforms, to simulate therapeutic responses. I have led innovative projects in vaccine prediction for Bovine coronavirus and the design of biomaterials targeting cardiac diseases and knee osteoarthritis. With over 5 years of collaborative experience, I have pioneered novel drug delivery strategies using biopolymer-induced nanomaterials and possess 4+ years of expertise in operating and interpreting data from advanced analytical instruments such as AFM, FESEM, UV-vis, and FTIR. Currently, as a Postdoctoral Research Fellow at Long Island University, I am leveraging organ-on-chip technologies to replicate human physiological responses, enhancing drug testing and validation processes. Known for creativity, quick learning, and self-motivation, I thrive in cross-functional teams and multicultural environments. My goal is to contribute to cutting-edge advancements in healthcare by advancing personalized therapies through biomaterial synthesis, predictive modeling, and drug delivery mechanisms to improve patient outcomes.
Research Experience
Research Grant Support: NIH Exploratory/Developmental Research Grant Award (R21)
Specialization Areas:
Title: In-vivo and In-vitro Studies on Bio-compatible Pure and Drug-loaded Biopolymer Induced Silver/Titanium Dioxide Core-shell Nanoparticles for Targeted Breast Cancer Therapy
Areas of Expertise
Independent Researcher
In-silico Protocols
Cell Culture Studies
Teaching and Mentorship
Journal Reviewer